These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 1350069

  • 1. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
    Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP.
    Neuroendocrinology; 1992 May; 55(5):600-8. PubMed ID: 1350069
    [Abstract] [Full Text] [Related]

  • 2. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.
    Sternberg EM, Young WS, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL.
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4771-5. PubMed ID: 2786636
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.
    Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL.
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2374-8. PubMed ID: 2538840
    [Abstract] [Full Text] [Related]

  • 4. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [Abstract] [Full Text] [Related]

  • 5. In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/N) rats.
    Zelazowski P, Smith MA, Gold PW, Chrousos GP, Wilder RL, Sternberg EM.
    Neuroendocrinology; 1992 Oct; 56(4):474-82. PubMed ID: 1335552
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats.
    Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW.
    Brain Res; 1992 Jan 20; 570(1-2):54-60. PubMed ID: 1319794
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1990 Apr 20; 126(4):1888-94. PubMed ID: 2156670
    [Abstract] [Full Text] [Related]

  • 8. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease.
    Zelazowski P, Patchev VK, Zelazowska EB, Chrousos GP, Gold PW, Sternberg EM.
    Brain Res; 1993 Dec 17; 631(1):22-6. PubMed ID: 8298992
    [Abstract] [Full Text] [Related]

  • 9. Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells.
    Wei R, Phillips TM, Sternberg EM.
    J Neuroimmunol; 2002 Oct 17; 131(1-2):31-40. PubMed ID: 12458034
    [Abstract] [Full Text] [Related]

  • 10. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 17; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 11. Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period.
    Aksentijevich S, Whitfield HJ, Young WS, Wilder RL, Chrousos GP, Gold PW, Sternberg EM.
    Brain Res Dev Brain Res; 1992 Jan 17; 65(1):115-8. PubMed ID: 1551226
    [Abstract] [Full Text] [Related]

  • 12. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE, Kamilaris TC, Johnson EO, Tartaglia ME, Chrousos G.
    Endocrinology; 1990 Oct 17; 127(4):1574-9. PubMed ID: 2169393
    [Abstract] [Full Text] [Related]

  • 13. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK, Kalogeras KT, Zelazowski P, Wilder RL, Chrousos GP.
    Endocrinology; 1992 Sep 17; 131(3):1453-7. PubMed ID: 1505475
    [Abstract] [Full Text] [Related]

  • 14. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro.
    Calogero AE, Gallucci WT, Bernardini R, Saoutis C, Gold PW, Chrousos GP.
    Neuroendocrinology; 1988 Apr 17; 47(4):303-8. PubMed ID: 2897641
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R, Chiarenza A, Kamilaris TC, Renaud N, Lempereur L, Demitrack M, Gold PW, Chrousos GP.
    Neuroendocrinology; 1994 Nov 17; 60(5):503-8. PubMed ID: 7845540
    [Abstract] [Full Text] [Related]

  • 16. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y, Aguilera G.
    Neuroendocrinology; 1992 Nov 17; 56(5):611-8. PubMed ID: 1336816
    [Abstract] [Full Text] [Related]

  • 17. Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats.
    Smith CC, Hauser E, Renaud NK, Leff A, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW, Sternberg EM.
    Brain Res; 1992 Jan 13; 569(2):295-9. PubMed ID: 1311618
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
    Calogero AE, Liapi C, Chrousos GP.
    J Endocrinol Invest; 1991 Apr 13; 14(4):277-86. PubMed ID: 1650804
    [Abstract] [Full Text] [Related]

  • 19. Differences in arylalkylamine N-acetyltransferase activity between inflammatory disease-susceptible Lewis and -resistant Fischer rats.
    Mastorakos G, Patchev VK, Chader GJ, Chrousos GP, Gaudet SJ.
    Neuroendocrinology; 1995 Jul 13; 62(1):71-8. PubMed ID: 7566441
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid negative feedback on the HPA axis in five inbred rat strains.
    Gómez F, De Kloet ER, Armario A.
    Am J Physiol; 1998 Feb 13; 274(2):R420-7. PubMed ID: 9486300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.